Q Sera
2 known investors
Q-Sera develops RAPClot, a recombinant ecarin-based clotting formulation used in rapid serum blood collection tubes. Its technology is incorporated into diagnostic blood tubes, such as Terumo's Venoject II range, for clinical laboratory use.
Investors · 2
Frequently asked questions
- What does Q Sera do?
- Q-Sera develops RAPClot, a recombinant ecarin-based clotting formulation used in rapid serum blood collection tubes. Its technology is incorporated into diagnostic blood tubes, such as Terumo's Venoject II range, for clinical laboratory use.
- Who are Q Sera's investors?
- Q Sera's investors include Stoic VC, UniSeed Pty Ltd..